Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sonnet Biotherapeutics Holdings Inc (NQ: SONN )

2.990 -0.080 (-2.61%)
Streaming Delayed Price Updated: 12:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,311
Open 3.100
Bid (Size) 2.910 (12)
Ask (Size) 2.990 (14)
Prev. Close 3.070
Today's Range 2.990 - 2.990
52wk Range 0.1904 - 4.800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology
Via ACCESSWIRE

Performance

YTD
+157.76%
+157.76%
1 Month
+931.03%
+931.03%
3 Month
+330.22%
+330.22%
6 Month
+732.64%
+732.64%
1 Year
+59.89%
+59.89%

More News

Read More
Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Sonnet BioTherapeutics Stock (SONN) Is Getting Obliterated
Via Benzinga
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
Via ACCESSWIRE
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Tower Semiconductor Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
What's Going On With Sonnet BioTherapeutics Stock Today?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Sonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US
Via ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
Via ACCESSWIRE
Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is SOFI Stock Up 19% Today?
Via InvestorPlace
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
Via ACCESSWIRE
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.